输注速率对尼索地平在人体中的药代动力学及血流动力学效应的影响。
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
作者信息
van Harten J, van Brummelen P, Zeegers R R, Danhof M, Breimer D D
机构信息
Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, Leiden, The Netherlands.
出版信息
Br J Clin Pharmacol. 1988 Jun;25(6):709-17. doi: 10.1111/j.1365-2125.1988.tb05257.x.
Abstract
- The pharmacokinetics and haemodynamic effects of nisoldipine on long term i.v. infusion of 2.40 mg and 9.59 mg in 25 h were studied in six healthy subjects. Liver blood flow at 0.8 and 24 h was assessed by measuring indocyanine green (ICG) clearance. 2. After high-dose nisoldipine, systemic clearance was 0.99 +/- 0.16 1 min-1, volume of distribution was 5.8 +/- 1.5 1 kg-1 and elimination half-life was 10.7 +/- 2.4 h. The pharmacokinetic parameters were similar after low-dose nisoldipine. 3. No significant changes in apparent liver blood flow were observed after either high-dose or low-dose nisoldipine. 4. Systolic blood pressure did not change, whereas diastolic blood pressure decreased by approximately 10% during both treatments. Maximal increase in heart rate was approximately 37% at high-dose infusion, whereas this was one half lower during the low-dose regimen. 5. Increased infusion rate results in an unfavourable shift in the haemodynamic effect profile of nisoldipine.
摘要
- 在6名健康受试者中研究了尼索地平在25小时内静脉输注2.40毫克和9.59毫克时的药代动力学和血流动力学效应。通过测量吲哚菁绿（ICG）清除率评估0.8小时和24小时时的肝血流量。2. 高剂量尼索地平后，全身清除率为0.99±0.16升/分钟，分布容积为5.8±1.5升/千克，消除半衰期为10.7±2.4小时。低剂量尼索地平后的药代动力学参数相似。3. 高剂量或低剂量尼索地平后，表观肝血流量均未观察到显著变化。4. 收缩压未改变，而两种治疗期间舒张压均下降约10%。高剂量输注时心率最大增加约37%，而低剂量方案时则低一半。5. 输注速率增加会导致尼索地平血流动力学效应曲线出现不利变化。
相似文献
1
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.输注速率对尼索地平在人体中的药代动力学及血流动力学效应的影响。
Br J Clin Pharmacol. 1988 Jun;25(6):709-17. doi: 10.1111/j.1365-2125.1988.tb05257.x.
2
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.
J Clin Pharmacol. 1989 Aug;29(8):714-21. doi: 10.1002/j.1552-4604.1989.tb03405.x.
3
Pharmacokinetics and hemodynamic effects of long-term nisoldipine treatment in hypertensive patients.
J Cardiovasc Pharmacol. 1989 Apr;13(4):624-9.
4
Single- and multiple-dose nisoldipine kinetics and effects in the young, the middle-aged, and the elderly.尼索地平单剂量和多剂量给药在年轻人、中年人和老年人中的药代动力学及效应
Clin Pharmacol Ther. 1989 Jun;45(6):600-7. doi: 10.1038/clpt.1989.80.
5
Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.
Eur J Clin Pharmacol. 1988;34(4):387-94. doi: 10.1007/BF00542441.
6
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.尼索地平引起的肝血流变化对其口服给药后药代动力学的影响。
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
7
Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.尼索地平的药代动力学和血流动力学效应及其与西咪替丁的相互作用。
Clin Pharmacol Ther. 1988 Mar;43(3):332-41. doi: 10.1038/clpt.1988.40.
8
The influence of nifedipine and captopril on liver blood flow in healthy subjects.硝苯地平和卡托普利对健康受试者肝血流量的影响。
Br J Clin Pharmacol. 1998 May;45(5):447-51. doi: 10.1046/j.1365-2125.1998.00709.x.
9
Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
Clin Pharmacokinet. 1989 Jan;16(1):55-64. doi: 10.2165/00003088-198916010-00004.
10
Maintenance of increased coronary blood flow in excess of demand by nisoldipine administered as an intravenous infusion.通过静脉输注尼索地平维持超过需求的冠状动脉血流量增加。
Am J Cardiol. 1986 Dec 1;58(13):1204-8. doi: 10.1016/0002-9149(86)90382-6.
引用本文的文献
1
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.理解药代动力学/药效动力学关系中的滞后环难题。
J Pharm Pharm Sci. 2014;17(1):34-91.
2
The influence of drug input rate on the development of tolerance to frusemide.药物输入速率对速尿耐受性发展的影响。
Br J Clin Pharmacol. 1998 Nov;46(5):479-87. doi: 10.1046/j.1365-2125.1998.00802.x.
3
Clinical pharmacokinetics of nisoldipine coat-core.尼索地平包芯片的临床药代动力学
Clin Pharmacokinet. 1998 Sep;35(3):191-208. doi: 10.2165/00003088-199835030-00003.
4
Influence of drug formulation on drug concentration-effect relationships.药物制剂对药物浓度-效应关系的影响。
Clin Pharmacokinet. 1994 Feb;26(2):135-43. doi: 10.2165/00003088-199426020-00006.
5
A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers.心血管药物作用动力学的数学模型：在健康志愿者中静脉注射二氢吡啶类药物的应用。
J Pharmacokinet Biopharm. 1993 Oct;21(5):489-514. doi: 10.1007/BF01059111.
6
Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers.输入速率对健康志愿者中（±）-伊拉地平血流动力学及浓度-效应关系的影响。
Eur J Clin Pharmacol. 1994;46(1):29-33. doi: 10.1007/BF00195912.
7
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.尼索地平。对其药效学、药代动力学特性以及治疗心绞痛、高血压和相关心血管疾病的疗效的初步综述。
Drugs. 1988 Dec;36(6):682-731. doi: 10.2165/00003495-198836060-00003.
8
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.尼索地平引起的肝血流变化对其口服给药后药代动力学的影响。
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
9
Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
Clin Pharmacokinet. 1989 Jan;16(1):55-64. doi: 10.2165/00003088-198916010-00004.
10
Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.钙通道拮抗剂：第六部分：第一代和第二代药物的临床药代动力学
Cardiovasc Drugs Ther. 1989 Aug;3(4):482-97. doi: 10.1007/BF01865507.
本文引用的文献
1
Model-independent steady-state volume of distribution.
J Pharm Sci. 1982 May;71(5):597-8. doi: 10.1002/jps.2600710532.
2
Hemodynamic effects of nisoldipine in chronic congestive heart failure.尼索地平对慢性充血性心力衰竭的血流动力学影响。
Arzneimittelforschung. 1983;33(6):877-9.
3
Energy conservation by nisoldipine in ischaemic heart.尼索地平对缺血性心脏的能量守恒作用。
Br J Pharmacol. 1984 Dec;83(4):943-9. doi: 10.1111/j.1476-5381.1984.tb16535.x.
4
Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.血流动力学变化对维拉帕米和硝苯地平消除动力学的影响。
J Pharmacol Exp Ther. 1984 Nov;231(2):301-5.
5
Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.硝苯地平可增加正常受试者的肝脏表观血流量，而硝酸甘油则使其降低。
Br J Clin Pharmacol. 1984 Jan;17(1):83-5. doi: 10.1111/j.1365-2125.1984.tb05003.x.
6
The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.新型钙拮抗剂尼索地平在血压正常和高血压受试者中的药效学和药代动力学。
Eur J Clin Pharmacol. 1985;29(1):21-4. doi: 10.1007/BF00547363.
7
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.尼索地平对表观肝血流量和有效肾血浆流量的影响。
Br J Clin Pharmacol. 1985 Sep;20(3):235-7. doi: 10.1111/j.1365-2125.1985.tb05066.x.
8
Verapamil pharmacokinetics and apparent hepatic and renal blood flow.维拉帕米的药代动力学及表观肝血流量和肾血流量
Br J Clin Pharmacol. 1985 Aug;20(2):101-6. doi: 10.1111/j.1365-2125.1985.tb05038.x.
9
Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.
Am Heart J. 1985 Aug;110(2):496-8. doi: 10.1016/0002-8703(85)90180-2.
10
Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in conscious rats at rest and during treadmill exercise.尼索地平对清醒大鼠静息及跑步机运动时心脏循环动力学和心输出量分布的影响。
J Pharmacol Exp Ther. 1985 Feb;232(2):376-81.
Zotero 插件